학술논문
Authors' response.
Document Type
Article
Source
Subject
*LETTERS to the editor
*INFLIXIMAB
*INFLAMMATORY bowel disease treatment
*
*
Language
ISSN
0017-5749
Abstract
A response by H. H. Fidder and colleagues to a letter to the editor regarding their article "Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study" in the 2009 issue is presented.